Computational methods
All ab initio and DFT calculations were performed by using the GAUSSIAN 03 program package. [3] Molecular structures of all compounds were fully optimized at various levels. Geometry optimizations were firstly carried out at the HF level with the 6-31+G(d,p) basis set and afterward the effect of electron correlation on the molecular geometry was taken into account by using Becke's three-parameter hybrid, and the gradient corrected Lee-Yang-Parr correlational functional (B3LYP) [4] employing 6-31+G(d,p) basis set. Vibrational frequency calculations were performed at the same level used for the geometry optimization.
For iodine compound (3) Gaussian-type basis set 6-31+G(d,p) we used for the C, O and H atoms and the quasi-relativistic effective core potential (RECP) SDD and valence basis sets recommended by Stuttgart group. [5] Syntesis and characterization 1 H (500MHz) and 13 C NMR (125 MHz) spectra were recorded on a Varian spectrometer using the solvent peak as internal reference.
ESI mass spectra were obtained on a Varian 310-MS LC/MS mass spectrometer, with the atmospheric pressure ionization (API) technique. The sample solutions (10 mg/L) were prepared in CH 3 CN and infused directly into the ESI source using a programmable syringe pump, with a flow rate of 1.50 mL/h. Needle, shield and detector were kept at 4800 V, 600 V and 1250 V, respectively.
Pressure of nebulizing and drying gas was 12 PSI, housing and drying gas temperature was 60 and 50 °C, respectively. Infrared spectrawere obtained using a Bruker-FT-IR. Optical rotation value were measured at 25°C using a PolAAr32. Melting points were obtained on a Kofler hot stage microscope. THF was distilled from sodium/benzophenone. Benzothiophene, hydroxyacetone, were used as purchased. Diol compound 3 was separated by chromatographic column (25mm x 180 mm) filled with DAVISIL silica gel (40-63 m), packed with Buchi C-670 cartridger.
3-bromo-1-Benzothiophene-2-(2-dioxolanyl)
was prepared from 3-bromo-1-Benzothiophene-2-carbaldehyde [6] as described in the literature. [7] 3-iodo-1-Benzothiophene-2--(2-dioxolanyl) was prepared from 3-bromo-1-Benzothiophene-2-(2-dioxolanyl) according to the literature. [8] To a solution of 3-bromo-1-benzothiophene-2-(2-dioxolanyl) (1.31 g, 4.58 mmol) in dietyl ether (25 mL) at -78 °C, t-BuLi (3.9 mL, 5.5 mmol,1.2 equiv.) was added dropwise. The reaction mixture was stirred for 1 at the same temperature and iodine (2.33 g, 9.16 mmol, 2 equiv in 10.0 mL diethyl ether) was added. The resulting mixture was allowed to room temperature and treated with an NH 4 Cl aq. And Na 2 S 2 O 3 extracted with diethyl ether. The organic phase was dried on Na 2 SO 4 and concentrated. Pure dioxolanyl compound was isolated after flash-chromatography, using petroleum ether/EtOAc (90:10) as eluent.
3-Iodo-1-benzothiophene-2-carbaldehyde.
A solution of aq. HClO 4 (70% 0.47 mL) in H 2 O (1.5mL) was added to solution of 3iodo-1-benzothiophene-2-(2-dioxolanyl) (1 g 3.47 mmol. ) in acetone (50 mL) at room temperature. The resulting mixture was stirred at room temperature for 24h. The resulting solution was extracted with diethyl ether (3x20 mL), washed with water and dried on Na 2 SO 4 . The crude product was purified by flash-chromatography (diethyl ether/petroleum ether 1:10) to give the corresponding product as red crystals (80% yield).Experimental data are consistent with those reported in literature. [9] Compounds 1,2,4 were synthesized according to the literature. [6] 
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